Associated Papers
Association of Carboxypeptidase B2 Gene Polymorphisms With Graft Loss in Kidney Transplantation.
Poppelaars F et al.
Transplantation Direct, 2026
Genetic Susceptibility to Adult Cerebral Venous Thrombosis: An Updated Meta-Analysis of Candidate Gene Studies.
Han G et al.
Stroke, 2026
Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.
Huang Q et al.
Peerj, 2023
Genetic Variants Contributing to Early Recurrent Pregnancy Loss Etiology Identified by Sequencing Approaches.
Quintero-Ronderos P et al.
Reproductive Sciences (thousand Oaks, Calif.), 2020
Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients.
Arauz A et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2018
Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.
Rattanawan C et al.
Thrombosis Research, 2018
Non-genetic and genetic risk factors for adult cerebral venous thrombosis.
Green M et al.
Thrombosis Research, 2018
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
Goetz MP et al.
Journal of the National Cancer Institute, 2017
Association between thrombin-activatable fibrinolysis inhibitor gene polymorphisms and venous thrombosis risk: a meta-analysis.
Wang W et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis, 2016
Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.
Qian K et al.
Gene, 2015
Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
Orikaza CM et al.
Thrombosis Research, 2014
Somatic signature of brain-specific single nucleotide variations in sporadic Alzheimer's disease.
Parcerisas A et al.
Journal of Alzheimer's Disease : Jad, 2014
TAFI gene polymorphisms in patients with cerebral venous thrombosis.
Tokgoz S et al.
Acta Neurologica Belgica, 2013
Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy.
Xu CW et al.
Journal of Endocrinological Investigation, 2012
Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.
Acosta-Tejeda M et al.
Thrombosis Research, 2011
Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.
Meltzer ME et al.
Journal of Thrombosis and Haemostasis : Jth, 2011
Boy with pseudohypoparathyroidism type 1a caused by GNAS gene mutation (deltaN377), Crouzon-like craniosynostosis, and severe trauma-induced bleeding.
Graul-Neumann LM et al.
American Journal of Medical Genetics. Part A, 2009
Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.
Bentov Y et al.
Plos One, 2009
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.
de Bruijne EL et al.
Journal of Thrombosis and Haemostasis : Jth, 2009
Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.
Meltzer ME et al.
Haematologica, 2009
[Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2008
Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
Sucker C et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2007
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
Martini CH et al.
British Journal of Haematology, 2006
Genetic and environmental influences on the fibrinolytic system: a twin study.
Peetz D et al.
Thrombosis and Haemostasis, 2004
The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.
Knoefler R et al.
Seminars in Thrombosis and Hemostasis, 2003
Novel Association of Thrombophilic PROS1, PROC and CPB2 Genes Polymorphisms with Recurrent Spontaneous Miscarriage Women in Jordan.
Al-Sanabra OM et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 0